NEW DELHI : India's Biological E. will produce the Johnson & Johnson COVID-19 vaccine alongside its own candidate, its managing director told Reuters on Tuesday, which could boost the country's overall supplies amid a shortage."The infrastructure and plants are completely separate for both the products and we will be producing both independent of each other," Mahima Datla said in a text message, declining to give any timeline or other detail.She told Reuters in February that Biological E.
was looking to contract-manufacture about 600 million doses of the J&J vaccine annually. India's government, however, did not factor in any production of J&J this year in the country in a list of likely vaccine output released last week.J&J said last month
Covid-19.rehab - the latest news concerning the spread of the SARS-CoV-2 coronavirus (formerly 2019-nCoV), as well as the infectious disease that it causes COVID-19, in separate countries and in the world as a whole. Current news on the topic of coronavirus SARS-CoV-2. Quarantine, pandemic 2020, epidemic: what is it, when will it come to end, precautions and how to protect yourself from this disease. The most honest news, no fakes! To keep up with the latest news, stay tuned for updates on the site! Every day we will collect news and statistics on coronavirus from around the world for you to be aware of this topic.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6